Performance against strategy

To be the cornerstone of healthcare services in South Africa, through the gift of life

Excellence

Aspiration

Achieve operational excellence that consistently produces efficient & effective products & services.

Strategic Priorities
  • Decrease wastage and promote appropriate use of blood
  • Improve efficiency of all identified and mapped processes
  • Enhance visibility of our value chain
  • Re-engineer procurement processes
  • Manage internal controls to acceptable levels
FY2021 Highlights
  • The launch of the Mount Edgecombe campus highlights our continuous dedication to becoming sustainable innovators in the industry through facilities that will benefit our staff, donors and visitors
  • The Journey of Blood will ensure we meet blood demands in KwaZulu-Natal and improve community health through various studies with renowned scientists. In terms of sustainability, it contributes to our vision of Greening SANBS which is in line with the UN 2030 sustainable development goals. This further underpins our commitment to ensure that SANBS not only becomes the cornerstone of healthcare in South Africa but all over the world.
Contributing to long-term sustainable value
Related material matters
  • Meeting blood demand
  • Future changing world
  • Sustainability
  • Transformation/change
Creating value for stakeholders Mission Metrics
Improving internal processes to be efficient and effective with acceptable levels of internal control Quality
Reduce wastage Cost
Ensuring correct blood type is delivered in an acceptable timeframe Reliability
Monitoring efficient use of resources Cost
Increasing SANBS’ social responsibility environmental impact and reducing cost Reliability & Cost
Monitoring our ability to deliver blood ordered by doctors Reliability
Monitoring unused blood to enable treatment actions if required Quality

KEY MEASURED INITIATIVES

Target achieved/exceeded
new initiative on track against current plan (no concerns) Target achieved/exceeded Improvement YOY No concerns yet Below target
Modernise ERP/SAP systems
Target IR 2019 IR 2020 Progress April 2020 to March 2021 Outlook for the year ahead 2021/2022 Target
Evaluate the current SAP ERP system, identify gaps and map out a clear ERP roadmap for the S4 HANA implementation. The objective is to implement a solution, which is intuitive, agile, scalable and mobile-ready, to improve operational excellence.
  • 90%
  • Evaluation complete
  • Work closely with HCM to build on change leadership capability to ensure successful implementation of SAP S4 HANA project
  • Conduct due diligence to ensure correct ERP investment is made
  • In FY 2021-22, focus is on getting the ERP system technically ready for the modernisation journey which includes the upgrade of our SAP system to SAP S4 HANA
  • Execution of ERP (S4 HANA) migration readiness initiatives including technical upgrades; finalisation of migration roadmaps for HR (Success Factors) and Procurement solution (Ariba or other).
Product Compliance to the Standards - Blood Product quality is critical to ensure that patients receive products of the highest quality
Target IR 2019 IR 2020 Progress April 2020 to March 2021 Outlook for the year ahead 2021/2022 Target
95% Not measured
  • 98.0%
  • 97%
  • In 2020/2021 a total of 35 853 (2%) of all products were tested and achieved a 97.7% result
  • 95%
  • For each product line, we assess which % of the individual products tested for a specified period of time, passed QC. If more than 80% of the products tested passed QC, then that product line met the Standard. This target must be achieved 95% of the time
Greening SANBS
Target IR 2019 IR 2020 Progress April 2020 to March 2021 Outlook for the year ahead 2021/2022 Target
Rollout Green awareness campaign, launch dashboard to monitor progress against indicators Relocation of H/O to Mount Edgecombe
  • 90%
  • Key focus remains to increase footprint for energy savings (solar, lighting adaptations, etc) and waste management.
Number of red cells issued as a % of the number of red cells ordered
Target IR 2019 IR 2020 Progress April 2020 to March 2021 Outlook for the year ahead 2021/2022 Target
>99%
  • 96.3%
  • 99.89%
  • 99.42%
  • >99%
  • Delivery to hospitals – reliability index
* Wastage – % of blood discarded
Target IR 2019 IR 2020 Progress April 2020 to March 2021 Outlook for the year ahead 2021/2022 Target
6.5%
  • 4.4%
  • 3.64%
  • 3.11%
    5.7%

* Note: #Use everything – reduce short bleeds is included in this measurement and remains 2.4% or less

Meet SLA TAT for standard crossmatches
Target IR 2019 IR 2020 Progress April 2020 to March 2021 Outlook for the year ahead 2021/2022 Target
>90% of standard crossmatches completed within agreed SLA TAT of 120 minutes
  • 57.11% of standard crossmatches completed with agreed SLA TAT of 120 minutes
  • 2019 reports included measures not a part of the standard crossmatch measurement; corrected latter half of 2020
  • 81.83% of standard crossmatches completed within agreed SLA TAT of 120 minutes.
  • The TAT for standard crossmatches is improving, primarily as a result of improved reporting
  • 90% of standard crossmatches completed within agreed SLA TAT of 120 minutes

    Navigate to